Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal ...

Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal epilepsy1Long-term seizure reduction with a median reduction of 82% ...

EpiWatch — a Johns Hopkins Medicine spinout — has received FDA 510(k) premarket clearance for its seizure detection platform ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

Today, the CBSA announced the interception and seizure of a combined 148.8 kilograms of methamphetamine, representing an estimated street value of $500,000, in six separate occasions at Vancouver ...

The Maryland Department of Health has confirmed that a resident who recently traveled abroad has contracted the measles. While this case remains unconn… ...

A eighth grader from Andover turned a personal moment into an invention that could bring peace of mind to those with epilepsy ...

People who are diagnosed with epilepsy have surges of electrical activity in their brain which can cause recurring seizures. For women, the diagnosis and treatment may affect their health in different ...

Gurgaon: Haryana seized 13,118 vehicles transporting minerals without valid documentation between Aug 2019 and Nov 2024, with ...

Today marks Purple Day, a national initiative to raise awareness about epilepsy. Charlene Kirk from the Epilepsy Foundation of Arkansas shared insights into the ...

Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces the initiation of scale-up and manufacturing of toxicology batches for SAN2219, advancing the program toward clinical ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...